Ionis Pharmaceuticals in (ions 0 04/01/26)
13F holders, Q2 2025 (June 30)6holders
0new positions
0sold out
$1.01avg. 13F price*
At the end of Q2 2025, 6 institutions reported holding Ionis Pharmaceuticals in (ions 0 04/01/26) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($503K), Bank of New York Mellon Corp ($202K) and Sonora Investment Management Group, LLC ($161K).
- Company
- Ionis Pharmaceuticals in (ions 0 04/01/26)
- CUSIP
- 462222AD2
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 2,001 shares bought and 101,000 shares sold, net −98,999 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | Add +0.0% | 500,000 | $503K |
| Bank of New York Mellon Corp | 0.00% | Reduce -33.3% | 200,000 | $202K |
| Sonora Investment Management Group, LLC | 0.01% | No change | 160,000 | $161K |
| Oppenheimer Asset Management Inc. | 0.00% | Reduce -1.1% | 92,000 | $92K |
| Boussard & Gavaudan Investment Management LLP | 0.01% | No change | 54,910 | $56K |
| Stephens Inc. | 0.00% | Add +8.3% | 26,000 | $26K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 0 04/01/26)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 0 04/01/26) the manager owns.